PepGen (PEPG) Enterprise Value (2021 - 2026)
PepGen (PEPG) reported Enterprise Value of -$132.3 million for Q1 2026, down 35.31% on a YoY basis from -$204.5 million in Q1 2025, and up 10.88% sequentially from -$148.5 million in Q4 2025.
PepGen (PEPG) Enterprise Value (2021 - 2026) Analysis & Trends
PepGen (PEPG) has 6 years of Enterprise Value data on file, last reported at -$132.3 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 35.31% year-over-year to -$132.3 million; the trailing twelve-month figure through Mar 2026 stood at -$132.3 million (down 35.31% YoY), and the FY2025 full-year result was -$148.5 million, down 23.52% from the prior year.
- Enterprise Value advanced to -$132.3 million in Q1 2026, from -$148.5 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$74.7 million in Q2 2025 to a low of -$218.8 million in Q2 2022.
- A 5-year average of -$145.9 million and a median of -$147.0 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value plunged 1682.72% in 2022 and jumped 53.72% in 2025, its largest moves.
- Tracing PEPG's Enterprise Value over 5 years: stood at -$181.8 million in 2022, then surged by 39.25% to -$110.4 million in 2023, then dropped by 8.86% to -$120.2 million in 2024, then slipped by 23.52% to -$148.5 million in 2025, then advanced by 10.88% to -$132.3 million in 2026.
- Business Quant data shows PEPG's Enterprise Value at -$132.3 million in Q1 2026, -$148.5 million in Q4 2025, and -$163.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | PepGen | 145.09 Mn | 145.09 Mn | - | -132.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -132.30 Mn |
| Dec 31, 2025 | -148.46 Mn |
| Sep 30, 2025 | -163.67 Mn |
| Jun 30, 2025 | -74.65 Mn |
| Mar 31, 2025 | -97.78 Mn |
| Dec 31, 2024 | -120.19 Mn |
| Sep 30, 2024 | -138.86 Mn |
| Jun 30, 2024 | -161.31 Mn |
| Mar 31, 2024 | -175.22 Mn |
| Dec 31, 2023 | -110.41 Mn |
| Sep 30, 2023 | -129.54 Mn |
| Jun 30, 2023 | -147.03 Mn |
| Mar 31, 2023 | -165.40 Mn |
| Dec 31, 2022 | -181.75 Mn |
| Sep 30, 2022 | -195.78 Mn |
| Jun 30, 2022 | -218.82 Mn |
| Mar 31, 2022 | -118.85 Mn |
| Dec 31, 2021 | -132.90 Mn |
| Sep 30, 2021 | -141.54 Mn |
| Jun 30, 2021 | -16.33 Mn |